María José Sáez-Lara

TL;DR: The use of probiotics and/or synbiotics has positive effects in the treatment and maintenance of UC, whereas in CD clear effectiveness has only been shown forsynbiotics.

TL;DR: This review critically discusses the evidence supporting the effects of NNSs, both synthetic sweeteners (acesulfame K, aspartame, cyclamate, saccharin, neotame, advantame, and sucralose) and naturalSweeteners (NSs; thaumatin, steviol glucosides, monellin, neohesperidin dihydrochalcone, and glycyrrhizin) and nutritive sweeteners

TL;DR: The oral intake of probiotics and synbiotics as co-adjuvants for the prevention and treatment of obesity, IRS, type 2 diabetes, T2D and NAFLD is partially supported by the data shown, however, further studies are required to understand the precise mechanism of how Probiotics and Synbiotics affect these metabolic disorders.

TL;DR: The microbes (mostly bacteria) identified in the endometrial microbiome studies are outlined, the current treatments offered for bacterial dysbiosis in the clinical setting, and the future possibilities such as pro- and prebiotics and microbial transplants for modifying uterine microbial composition are outlined.

TL;DR: It is hypothesized that the risk of breast cancer could be associated with the composition and functionality of the mammary/gut microbiota, and that exposure to environmental contaminants (endocrine disruptors, EDCs) might contribute to alter these microbiota.